INCENDIA THERAPEUTICS Trademark
Trademark Overview
On Tuesday, December 12, 2023, a trademark application was filed for INCENDIA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the INCENDIA THERAPEUTICS trademark a serial number of 98311406. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, December 13, 2024. This trademark is owned by Incendia Therapeutics Inc.. The INCENDIA THERAPEUTICS trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
monoclonal antibody products and preparations for the treatment of immune-excluded tumors found in recalcitrant cancers; pharmaceutical products and preparations consisting of monoclonal antibodies for the treatment of immune-excluded tumors found in recalcitrant cancers; pharmaceutical preparations developed with a computational platform engine using biology and chemistry analytics for the treatment of immune-excluded tumors found in recalcitrant cancers
monoclonal antibodies used in industry and science, and in the manufacture of pharmaceuticals, pharmaceutical preparations and substances, for the treatment of immune-excluded tumors found in recalcitrant cancers
drug discovery services for the discovery of monoclonal antibody-containing drugs, provided through a computational platform engine in the field of recalcitrant cancers
General Information
| Serial Number | 98311406 |
| Word Mark | INCENDIA THERAPEUTICS |
| Filing Date | Tuesday, December 12, 2023 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Friday, December 13, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | monoclonal antibody products and preparations for the treatment of immune-excluded tumors found in recalcitrant cancers; pharmaceutical products and preparations consisting of monoclonal antibodies for the treatment of immune-excluded tumors found in recalcitrant cancers; pharmaceutical preparations developed with a computational platform engine using biology and chemistry analytics for the treatment of immune-excluded tumors found in recalcitrant cancers |
| Goods and Services | monoclonal antibodies used in industry and science, and in the manufacture of pharmaceuticals, pharmaceutical preparations and substances, for the treatment of immune-excluded tumors found in recalcitrant cancers |
| NOT AVAILABLE | THERAPEUTICS |
| Goods and Services | drug discovery services for the discovery of monoclonal antibody-containing drugs, provided through a computational platform engine in the field of recalcitrant cancers |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 11, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 11, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, December 11, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Incendia Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Boston, MA 02135 |
Trademark Events
| Event Date | Event Description |
| Tuesday, December 12, 2023 | NEW APPLICATION ENTERED |
| Sunday, March 17, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 11, 2024 | ASSIGNED TO EXAMINER |
| Friday, July 12, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, July 12, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, July 12, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 9, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, October 9, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Friday, December 13, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, December 13, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 13, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
